Pfizer
PFE
PFE
2,399 hedge funds and large institutions have $180B invested in Pfizer in 2018 Q4 according to their latest regulatory filings, with 258 funds opening new positions, 778 increasing their positions, 1,124 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,399
Holders Change
+147
Holders Change %
+6.53%
% of All Funds
53.54%
Holding in Top 10
327
Holding in Top 10 Change
+67
Holding in Top 10 Change %
+25.77%
% of All Funds
7.3%
New
258
Increased
778
Reduced
1,124
Closed
86
Calls
$1.21B
Puts
$1.28B
Net Calls
-$74.9M
Net Calls Change
-$251M
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$1.76B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$965M |
| 3 |
BlackRock
New York
|
+$531M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$428M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$307M |
